Assessing Safety & Performance of the ANA Catheter System, Combined With a

Status Terminated

Clinical Trial Summary

The ANA catheter system (may also be designated as "ANA system", "ANA 18 -002" or "ANA device") is a distal access catheter designed to assist in neurovascular procedures by facilitating the insertion and guiding of other devices (i.e. retrieval devices and intravascular catheters) and restricting blood flow at the target position. It is a sterile, single-use, disposable intravascular device comprised of two coaxial catheters (delivery catheter and funnel catheter) consisting of sections of variable stiffness. The funnel catheter is comprised of a radiopaque nitinol braid (self-expanding funnel), covered by a continuous silicone coating that, when deployed, provides local and temporary flow restriction. The delivery catheter has a hydrophilic coating to reduce friction during use and a radiopaque marker on the distal end. Both catheters have Luer lock hubs on their proximal end. The proposed study has been designed to collect prospective clinical evidence to compare the Anaconda ANA device to similar devices used for guiding and supporting stent retrievers during neurothrombectomy procedures. The protocol has been designed to replicate the patient population enrolled in prior studies of similar devices. The primary endpoint will be ability of the investigational device to facilitate stentriever deployment and neurothrombectomy in the anterior circulation, with successful reperfusion defined as achieving a modified Thrombolysis in Cerebral Infarction (mTICI) score of ≥2b in the target vessel with ≤3 passes of the investigational device without the use of rescue therapy. Follow-up at 24h, Day 5 (+/- 12 h) or discharge, whichever comes first and at 90 days will allow documentation of the clinical outcome of the neurothrombectomy procedure as a whole and detect any device related and other complications, making use of the ANA device for distal access.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04095767
Study type	Interventional
Source	Anaconda Biomed S.L.
Contact
Status	Terminated
Phase	N/A
Start date	September 21, 2019
Completion date	June 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03993236` - Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke	Phase 4
Completed	`NCT04069767` - Innovative Physiotherapy in Stroke Rehabilitation	N/A
Recruiting	`NCT06342206` - The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Enrolling by invitation	`NCT04956211` - Periodontal Treatment and Ischemic Stroke	N/A
Active, not recruiting	`NCT05098236` - Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage	N/A
Completed	`NCT03942588` - High-intensity Interval Training After Stroke	N/A
Recruiting	`NCT04949334` - Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke	N/A
Not yet recruiting	`NCT06352086` - Understanding Visual Processing After Occipital Stroke
Withdrawn	`NCT04991038` - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients	N/A
Completed	`NCT01937182` - The Efficacy of Citalopram Treatment in Acute Stroke	Phase 2
Completed	`NCT03649295` - Combined Conventional Speech Therapy and Functional Electrical Stimulation in Dysphagia Following Stroke	N/A
Recruiting	`NCT05303649` - Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia	N/A
Completed	`NCT04233515` - Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Completed	`NCT05102877` - Sensory Versus Motor Level Neuromuscular Electrical Stimulation	N/A
Completed	`NCT04089917` - A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients
Completed	`NCT05221112` - Effects of PNF Patterns Training on Trunk Balance, and Gait in Chronic Stroke Patients	N/A
Not yet recruiting	`NCT05035953` - Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke	Phase 2
Completed	`NCT06326801` - Resistive Diaphragmatic Breathing Exercise With Pursed Lips Breathing Exercise in Sub-acute Stroke Patients	N/A
Not yet recruiting	`NCT05210088` - PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessing Safety and Performance of the ANA Catheter System, Combined With a Stent Retriever in Acute Ischemic Stroke — SOLONDA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms